S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

Georgeanna Seegar Jones Inducted Into National Women's Hall of Fame

Decades after pioneering the protocols that birthed America’s first IVF baby, Dr. Georgeanna Seegar Jones has been enshrined in the National Women's Hall of Fame. Her induction recognizes a career defined by breakthrough discoveries in reproductive physiology that transformed the landscape of infertility treatment in the United States.

Georgeanna Seegar Jones Inducted Into National Women's Hall of Fame
Photo: Bio & News

The late physician’s journey began in 1938 at Johns Hopkins University, where she challenged medical consensus by proving the placenta—not the pituitary gland—produces human chorionic gonadotropin. This discovery paved the way for her later work in the 1970s, where she refined IVF techniques by integrating hormonal therapies that significantly increased success rates. Her clinical protocols were instrumental in the 1981 birth of Elizabeth Carr, the first American IVF infant.

To mark her induction, the Howard and Georgeanna Jones Foundation for Reproductive Medicine is partnering with the American Society for Reproductive Medicine to launch a $100,000 grant. The Georgeanna Seegar Jones, MD, Women of the Hall Investigative Scientist Award will provide bridge funding for research aimed at advancing assisted reproductive technology. Robert W. Jones, Chairman of the Foundation, noted that the grant honors a legacy of scientific innovation that continues to drive modern reproductive medicine.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!